Skip to content

Sanara MedTech Inc. SMTI Net Investment in Lease

Net Investment in Lease at other companies

IAR
Integra LifeSciencesIART
Solventum logo
SolventumSOLV
ClearPoint Neuro logo
ClearPoint NeuroCLPT
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
Anika Therapeutics logo
Anika TherapeuticsANIK

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s net investment in lease?
Sanara MedTech Inc. (SMTI) reported net investment in lease of $1.99M in Q1 2026.
How has Sanara MedTech Inc.'s net investment in lease changed year-over-year?
Sanara MedTech Inc.'s net investment in lease increased by 69.9% year-over-year, from $1.17M to $1.99M.
What is the long-term trend for Sanara MedTech Inc.'s net investment in lease?
Over 5 years (2020 to 2025), Sanara MedTech Inc.'s net investment in lease has grown at a 34.7% compound annual growth rate (CAGR), from $467.65K to $2.08M.